Hetrazan

Active Ingredient(s): Diethylcarbamazine citrate, DEC
FDA Approved: * November 13, 1950
Pharm Company: * LEDERLE
Category: Antiprotozoal / Anthelmintic

Diethylcarbamazine (DEC) is a medication used in the treatment of filariasis including lymphatic filariasis, tropical pulmonary eosinophilia, and loiasis.[1] It may also be used for prevention of loiasis in those at high risk.[1] While it has been used for onchocerciasis (river blindness), ivermectin is preferred.[2] It is taken by mouth.[3] Common side effects include itching, facial swelling, headaches, and feeling tired.&#... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
25 Discussions